ar-709 and Respiratory-Tract-Infections

ar-709 has been researched along with Respiratory-Tract-Infections* in 1 studies

Other Studies

1 other study(ies) available for ar-709 and Respiratory-Tract-Infections

Article	Year
In vitro activity of AR-709 against Streptococcus pneumoniae. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3 We investigated the in vitro activity of AR-709, a novel diaminopyrimidine antibiotic currently in development for treatment of community-acquired upper and lower respiratory tract infections, against 151 Streptococcus pneumoniae strains from various European countries. AR-709 showed excellent activity against both drug-susceptible and multidrug-resistant pneumococci. Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Europe; Humans; Microbial Sensitivity Tests; Pyrimidines; Respiratory Tract Infections; Streptococcus pneumoniae	2008

Article

Year

In vitro activity of AR-709 against Streptococcus pneumoniae.

Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

We investigated the in vitro activity of AR-709, a novel diaminopyrimidine antibiotic currently in development for treatment of community-acquired upper and lower respiratory tract infections, against 151 Streptococcus pneumoniae strains from various European countries. AR-709 showed excellent activity against both drug-susceptible and multidrug-resistant pneumococci.

Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Europe; Humans; Microbial Sensitivity Tests; Pyrimidines; Respiratory Tract Infections; Streptococcus pneumoniae

2008